REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139
FDA 510(k) clearance K032868 · decided 2003-10-14
Clearance details
- K-number
- K032868
- Device name
- REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139
- Applicant
- Corgenix, Inc.
- Decision
- Substantially Equivalent
- Date received
- 2003-09-15
- Decision date
- 2003-10-14
- Days to decision
- 29 days
- Clearance type
- Special
- Product code
- MID
- Device class
- 2
- Regulation number
- 866.5660
- Medical specialty
- Immunology
- Advisory committee
- Immunology
- Location
- Westminster, CO, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Corgenix
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
Recalls involving this device
| Record | Firm | Date |
|---|---|---|
| BIO-RAD 425-2020 Autoimmune EIA Anti-Cardiolipin IgM, 96 Tests...2010 02 16...Lot CL-863. recall (Z-1145-2010) | Bio-Rad Laboratories Inc | 2010-03-16 |